Read more about Biotech cos Tzar Labs and Epigeneres to launch early-detection cancer tests on Business Standard. Firms claim breakthrough with their RNA-marker tech which detects cancer even in stage zero
Biotech startups Tzar Labs, Epigeneres Biotechnology claim breakthrough in cancer detection using novel blood test yourstory.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yourstory.com Daily Mail and Mail on Sunday newspapers.
Singapore based, Tzar Labs, a molecular diagnostic company, along with Mumbai-based Epigeneres Biotechnology, claimed an unprecedented breakthrough in early
Tzar Labs announces breakthrough in early-stage cancer with simple blood test
Tzar Labs announces breakthrough in early-stage cancer with simple blood test
Last Updated: Fri, May 7th, 2021, 19:20:20hrs
New Delhi, May 7 (IANS) Singapore based, Tzar Labs, a molecular diagnostic company, along with Mumbai-based Epigeneres Biotechnology, claimed an unprecedented breakthrough in early-detection and prognosis/diagnosis of cancer. This is possible with a novel blood test - a world-first - that can help determine whether cancer is absent, imminent, or present, and also detect different stages of the disease, a company statement said.
This will pave the way for widespread early detection and treatment of cancer, thereby potentially saving millions of lives. This innovation will redefine cancer diagnostics through precise and accurate detection before any symptoms or tumours develop, it said.